TGDS
Basic information
Region (hg38): 13:94574054-94596242
Links
Phenotypes
GenCC
Source:
- Catel-Manzke syndrome (Definitive), mode of inheritance: AR
- Catel-Manzke syndrome (Strong), mode of inheritance: AR
- Catel-Manzke syndrome (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Catel-Manzke syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal | 6011685; 9777339; 18501694; 22887726; 25480037 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TGDS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 13 | ||||
missense | 27 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 2 | 4 | 1 | 7 | ||
non coding | 19 | 27 | ||||
Total | 0 | 5 | 28 | 21 | 22 |
Variants in TGDS
This is a list of pathogenic ClinVar variants found in the TGDS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-94574785-T-C | Likely benign (Apr 10, 2023) | |||
13-94574789-G-A | Benign (Sep 11, 2023) | |||
13-94574796-G-A | Inborn genetic diseases | Uncertain significance (Jan 03, 2024) | ||
13-94574801-A-G | Uncertain significance (Dec 04, 2023) | |||
13-94574821-C-G | Likely pathogenic (Apr 01, 2024) | |||
13-94574839-T-C | Likely benign (Oct 10, 2018) | |||
13-94574860-G-A | Likely benign (Jan 24, 2018) | |||
13-94574874-CA-C | Benign (May 17, 2021) | |||
13-94574874-C-CA | Benign (May 15, 2021) | |||
13-94574884-AAAG-A | Benign (May 16, 2021) | |||
13-94574885-AAG-A | Benign (May 15, 2021) | |||
13-94575086-C-T | Benign (Nov 12, 2018) | |||
13-94576339-A-G | TGDS-related disorder | Likely benign (Aug 17, 2023) | ||
13-94576352-C-A | Inborn genetic diseases | Uncertain significance (Dec 18, 2023) | ||
13-94576404-T-C | Catel-Manzke syndrome | Pathogenic (Dec 04, 2014) | ||
13-94576413-T-G | Catel-Manzke syndrome | Uncertain significance (May 14, 2019) | ||
13-94577371-C-T | not specified | Uncertain significance (Feb 19, 2024) | ||
13-94577421-C-G | Inborn genetic diseases | Uncertain significance (Aug 08, 2022) | ||
13-94577443-A-G | Benign (Jan 15, 2024) | |||
13-94577481-A-G | Benign (May 20, 2021) | |||
13-94577852-CTTAAT-C | Benign (May 15, 2021) | |||
13-94577985-C-A | Likely benign (Mar 20, 2023) | |||
13-94578001-A-T | Uncertain significance (Jul 17, 2023) | |||
13-94578037-C-T | Inborn genetic diseases | Uncertain significance (Aug 17, 2021) | ||
13-94578089-T-C | Likely benign (Feb 20, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TGDS | protein_coding | protein_coding | ENST00000261296 | 12 | 22204 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.48e-9 | 0.467 | 125698 | 0 | 50 | 125748 | 0.000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.300 | 168 | 179 | 0.937 | 0.00000832 | 2303 |
Missense in Polyphen | 63 | 67.097 | 0.93893 | 883 | ||
Synonymous | 1.69 | 45 | 61.9 | 0.727 | 0.00000302 | 612 |
Loss of Function | 1.04 | 16 | 21.2 | 0.756 | 8.92e-7 | 284 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000675 | 0.000646 |
Ashkenazi Jewish | 0.000405 | 0.000397 |
East Asian | 0.000231 | 0.000217 |
Finnish | 0.0000927 | 0.0000924 |
European (Non-Finnish) | 0.000164 | 0.000158 |
Middle Eastern | 0.000231 | 0.000217 |
South Asian | 0.000352 | 0.000327 |
Other | 0.000197 | 0.000163 |
dbNSFP
Source:
- Disease
- DISEASE: Catel-Manzke syndrome (CATMANS) [MIM:616145]: A syndrome characterized by Pierre Robin sequence and a unique form of bilateral hyperphalangy causing a clinodactyly of the index finger. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). {ECO:0000269|PubMed:25480037}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.225
Intolerance Scores
- loftool
- 0.490
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.75
Haploinsufficiency Scores
- pHI
- 0.233
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.621
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.755
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tgds
- Phenotype
- craniofacial phenotype; growth/size/body region phenotype; digestive/alimentary phenotype; skeleton phenotype;
Gene ontology
- Biological process
- Cellular component
- Molecular function
- dTDP-glucose 4,6-dehydratase activity